Two founders are launching a biotech startup. They expect operating losses for the first $3$ years, followed by rapid growth. Their goals are:

To deduct early losses against other income

To attract venture capital within $23$ years

To eventually exit via an IPO or acquisition

To retain flexibility in profit$/$loss allocation until investment comes in

Which of the following best reflects the optimal sequence of entity choices for minimizing taxes and maximizing strategic value?